Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.160
+0.005 (0.43%)
At close: Sep 17, 2026, 4:00 PM EDT
1.190
+0.030 (2.59%)
After-hours: Sep 17, 2026, 5:37 PM EDT
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $18.46 million as of September 17, 2026. Its market cap has decreased by -16.94% in one year.
Market Cap
18.46M
Enterprise Value
23.76M
1-Year Change
-16.94%
Ranking
Category
Stock Price
$1.16
ChartMarket Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $18.46M, a decrease of -76.75%. That is a compound annual growth rate of -26.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 18.46M | 8.15% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 20.27M |
| Akari Therapeutics, | 19.70M |
| NewcelX | 19.58M |
| Tempest Therapeutics | 19.34M |
| Jasper Therapeutics | 19.33M |
| Chemomab Therapeutics | 19.20M |
| Marker Therapeutics | 19.01M |
| BioCardia | 18.92M |